Continuing Treatment for Children and Adults in the Center for Cancer Research
Data Collection
Collected from today forward - ProspectiveNeoplasms
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: January 29, 1992
Actual date on which the first participant was enrolled.Background: It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol. Objective: To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol. Eligibility: Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol. (clinical trial) It is in the best interest of the subject and the CCR for the subject to continue to receive standard care and follow-up at the NIH. Design: Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on an active research protocol. No investigational treatments will be administered. This protocol is not be used as a platform to perform pilot studies of off-label uses for standard agents.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.2145 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Until 99 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
INCLUSION CRITERIA: Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol. It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH. The subject or guardian signs the informed consent and agrees to the proposed treatment regimen. EXCLUSION CRITERIA: Subjects who have not been previously treated on a CCR research treatment protocol. Subjects who are receiving an investigational therapy.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, United StatesOpen National Institutes of Health Clinical Center, 9000 Rockville Pike in Google Maps